Table 2.

Demographics. Dose escalation phase (n=21)

Characteristic	Category	Number	% of Cases
Age (years)	17–49 years	2	10
	50–59 years	7	33
	60–69 years	8	38
	70–79 years	4	19
	80–89 years
Ethnicity	Hispanic	1	5
	White	18	85
	Asian	2	10
	Black	0
Performance Status	0	14	66
	1	4	19
	2	3	15
Site of Disease	Ovary	18	85
	Fallopian tube	0
	Primary Peritoneal	3	15
Stage	IIb	0
	IIc	0
	IIIa	4	19
	IIIb	1	5
	IIIc	15	71
	IV	1	5
Debulking	Optimal	14	67
	Suboptimal > 1cm	7	33
Measurable Disease	No	14	67
	Yes	7	33